BDNF and malignant colon neoplasm: In colon cancer, low expression of BDNF-AS1 can upregulate glycogen synthase kinase-3+, thereby inhibiting the proliferation, invasion, and metastatic ability of colon cancer cells (Zhi and Lian, 2019).